An agreement paves the way for hundreds of millions of dollars’ worth of projects to be transferred from the NIH’s institute for infectious diseases to the Department of Defense.

The United Nations warns the world is very close to crossing a dangerous climate change threshold in a new report.

Taking inspiration from Dolly Parton and Canada’s Mark Carney

Monterey Bay Aquarium joined 23 organizations to speak up for state and local knowledge in protecting coasts.

This Medical News article discusses how the ongoing US cyclosporiasis outbreak, centered in Michigan, exposed weaknesses in the nation’s foodborne disease surveillance system and what needs to change ...

'It makes about as much sense as when he said we should drink bleach,' the vaccine expert says

Sprig & Sprout Jack & Olive and Cibus Fresh garden salads are being recalled for possible cyclospora contamination. Because this recall notice is

This year, many health experts are worried that decisions about vaccination — how many shots to get and when to get them – may be unnecessarily complicated because of a new executive order.

“Based on simple math, these outbreak responses—which require rapid, timely responses—are going to be greatly diminished,” the former CDC lab director tells WIRED.

mRNA vaccines represent a transformative advance in vaccinology, combining rapid development timelines, scalable manufacturing, and strong immunogenicity with a favourable safety profile. Global deplo...

The COVID vaccine study that was suppressed by acting CDC director earlier this year has now been published in a JAMA journal. Originally slated to appear in March in the CDC's MMWR, the study was re...

A Review of the immunological mechanisms of mRNA–lipid-nanoparticle vaccines for infectious diseases discusses how the components of this vaccine platform can be modified to fine-tune immune responses...

The Food and Drug Administration approved a new sunscreen ingredient in the U.S. for the first time in 20 years. It's been used for decades in Europe and Asia.

Two experimental drug molecules promoted myelin repair in MS disease models, pointing toward a possible future route for treating nerve damage rather than only suppressing inflammation.